Singular Genomics
Biotechnology ResearchCalifornia, United States51-200 Employees
Singular Genomics is a biotechnology research company located in San Diego, California, with a workforce of about 51 to 200 employees. It develops spatial pathology technologies, most notably the G4X Platform, described as a high-throughput in situ multiomics system intended to advance precision diagnostics and personalized medicine. In 2026 the company launched G4X in the United States and established collaborations, including with Vanderbilt University Medical Center to support the HTAN Pre-Gastric Cancer program and with Tecan Group AG to develop customized reagent kits for NGS library preparation. John Stark was named Chief Executive Officer in April 2026, as the company continues to build on momentum around its spatial platform. Financial disclosures indicate revenue in the tens of millions and total funding around $131 million.